We’re excited to announce that the ePrescribing experience within Hint Clinical is getting an upgrade with the integration of Dosespot! This upgrade will provide faster prescribing, improved reliability, and better patient care for Hint Clinical users.

This move to Dosespot signifies our unwavering commitment to providing you with the best possible tools to streamline workflows and deliver exceptional patient care. Dosespot offers industry-leading speed and uptime, ensuring you can prescribe medications quickly and efficiently, without interruptions.

About Dosespot

Dosespot is a stable, fast and user-friendly ePrescribing platform built specifically for Direct Primary Care (DPC) clinicians. It integrates seamlessly with your Hint Clinical dashboard, letting you prescribe medications in seconds. Dosespot prioritizes patient safety with real-time drug interaction alerts and ensures compliance with state regulations. Reduce errors, streamline workflow, and improve patient care with Dosespot.

Dosespot includes:

• Faster Prescribing: Less time spent on prescribing means more focused time with your members.
• Unmatched Uptime: Focus on patient care, confident that Dosespot is always available.
• Enhanced Patient Safety: Built-in safeguards minimize medication errors and ensure accurate prescriptions.

What’s Next?

We've started transitioning practices to Dosespot and will continue transitioning practices over a staggered timeline. If your practice uses Hint Clinical, your team will receive an email from us approximately 2 weeks before being transitioned with requests for prescriber information to set up your practice with Dosespot.

If you have any questions please contact us at support@hint.com.

We understand the importance of a reliable ePrescribing solution and our team is excited to bring you this upgrade. By integrating Dosespot with Hint Clinical, we're empowering you to deliver a superior patient experience, free from the concerns of system outages and inefficiencies. Stay tuned for next steps and more information as we transition practices to Dosespot in the coming months.